Physician profile
Brandy Crowson
NPI 1518502160
$1,220.38
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $373 · 2022: $225 · 2023: $481 · 2024: $141.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $622.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $621.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $230.72 | 2021-2023 | Cuvitru |
| Glaxosmithkline, LLC. | $136.23 | 2021-2023 | Bexsero |
| Servier Pharmaceuticals LLC | $132.71 | 2023 | |
| Jazz Pharmaceuticals INC. | $124.99 | 2024 | |
| Xeris Pharmaceuticals, INC. | $124.99 | 2023 | Gvoke Hypopen |
| Regeneron Healthcare Solutions, INC. | $123.12 | 2022 | |
| Tris Pharma INC | $116.54 | 2021-2022 | |
| Sobi, INC | $72.48 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $54.27 | 2021 | |
| Nestle Healthcare Nutrition INC. | $20.20 | 2021 | |
| Cranial Technologies, INC | $19.70 | 2022 | |
| Corium, LLC | $18.68 | 2022 | |
| Pfizer INC. | $16.74 | 2021 | |
| Azurity Pharmaceuticals, INC. | $16.02 | 2024 | Katerzia |
| Cumberland Pharmaceuticals, INC. | $12.99 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brandy Crowson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.